Trial of Reduced Alteplase Dose for Parapneumonic Effusion (TRAPPE)

PHASE2/PHASE3RecruitingINTERVENTIONAL

Enrollment

Participants

Timeline

Start Date

November 1, 2024

Primary Completion Date

March 31, 2028

Study Completion Date

June 30, 2028

Conditions

Pleural Infection

Interventions

DRUG

Tissue Plasminogen Activator

Intrapleural administration of tissue plasminogen activator

Trial Locations (2)

RECRUITING

Chinese University of Hong Kong, Hong Kong

RECRUITING

Prince of Wales Hospital, Hong Kong

All Listed Sponsors

lead

Chinese University of Hong Kong

OTHER